Cynomolgus monkey dickkopf-4, nucleotides encoding same, and uses thereof
View Patent ↗The cynomolgus monkey Dickkopf-4 (cDkk-4) protein, isolated nucleic acid molecules which encode the cDkk-4 protein, and recombinant vectors and hosts comprising DNA encoding the cDkk-4 protein are disclosed. Also disclosed are methods for identifying analytes which interfere with the interaction between the cDkk-4 protein and a homologous or heterologous Dkk receptor and analytes which interfere with the interaction and stimulate bone formation. Analytes identified using the methods are useful for treating osteoporosis and other bone loss disorders.
1. An isolated nucleic acid molecule comprising a nucleotide sequence encoding a cynomolgus monkey Dickkopf-4 (cDkk-4) protein comprising the amino acid sequence as set forth in SEQ ID NO:2.
2. The isolated nucleic acid of claim 1 wherein the nucleic acid is a DNA.
3. The isolated nucleic acid of claim 1 wherein the nucleic acid is an RNA.
4. The isolated nucleic acid of claim 1 wherein the nucleic acid is a cDNA.
5. The isolated nucleic acid of claim 1 wherein the nucleic acid has the nucleotide sequence as set forth in SEQ ID NO:1.
6. An isolated protein comprising the amino acid sequence as set forth in SEQ ID NO:2.
7. A method for producing a cynomolgus monkey Dickkopf-4 (cDkk-4) protein comprising the amino acid sequence as set forth in SEQ ID NO:2 which binds a low-density lipoprotein receptor protein 5 (LRP5) comprising:
(a) providing a nucleic acid encoding the cDkk-4 protein operably linked to a heterologous promoter;
(b) introducing the nucleic acid into a cell to produce a recombinant cell; and
(c) culturing the recombinant cell under conditions which allows expression of the cDkk-4 protein to produce the cDkk-4.
8. A method for determining whether an analyte is an antagonist of Dickkopf4 (Dkk-4) binding comprising:
(a) providing a polypeptide comprising the extracellular domain of a Dkk-4 receptor;
(b) contacting the polypeptide with a cynomolgus monkey Dkk-4 (cDkk-4)protein comprising the amino acid sequence as set forth in SEQ ID NO:2 and the analyte; and
(c) determining whether binding of the cDkk-4 to the polypeptide is decreased in the presence of the analyte, wherein a decrease in the binding indicates that the analyte is an antagonist of cDkk-4 binding.
9. The method of claim 8 , wherein the Dkk-4 receptor is low-density lipoprotein receptor related protein 5 (LRP5) or low density lipoprotein receptor related protein 6 (LRP6).
10. The method of claim 8 , wherein the Dkk-4 receptor is kremen 1 or kremen2.
11. The method of claim 8 wherein the cDkk-4 is labeled.
12. The method of claim 8 wherein the cDkk-4 is a fusion protein.